Company news: Eli Lilly and Novartis

Share this article:

Eli Lilly is expanding its Indiana insulin manufacturing operations, marking the first expansion of the company's Indianapolis sites in more than twenty years. The company will provide more details Thursday, but noted in a statement that the new capacity is to meet US demand. The site will make insulin cartridges.

Novartis continues to focus on making Singapore its biotech and manufacturing hub. The company announced Wednesday that it was investing more than $500 million in building a manufacturing facility that will focus on drugs based on cell culture technology. The company said in a statement it expects work to wrap by 2016, and the site will be able to scale up or down to handle a variety of production volumes.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters